Skip to main content
Erschienen in: Modern Rheumatology 5/2011

01.10.2011 | Original Article

Phonoarthrography, musculoskeletal ultrasonography, and biochemical biomarkers for the evaluation of knee cartilage in osteoarthritis

verfasst von: Hassan M. Bassiouni, Mamoun El-Deeb, Nasser Kenawy, Ehab Abdul-Azim, Mamdouh Khairy

Erschienen in: Modern Rheumatology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to examine the relationship among three different parameters used to assess cartilage in osteoarthritis (OA) of the knee. These parameters are phonoarthrography (Phono-A), musculoskeletal ultrasonography (MSUS) from the 4 condyles, and biochemical markers; notably, matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of proteinase (TIMP-1). A total of 100 knees with chronic idiopathic OA diagnosed according to the American College of Rheumatology (ACR) criteria were studied, together with 50 normal knees. The knee sounds were recorded by Phono-A and the cartilage thickness was measured by MSUS. All patients and controls had MMP-3 and TIMP-1 measured in a blood sample, using an enzyme-linked immunosorbent assay (ELISA). Conventional knee X-rays were obtained for diagnosis and for Kellgren–Lawrence (K-L) grading purposes. The results showed that Phono-A values were inversely correlated with cartilage thickness, both of these being sensitive parameters for cartilage degeneration. Phono-A values were higher in patients than in controls, denoting more degeneration of cartilage, and the cartilage thickness of all 4 condyles showed significant reductions in patients compared with normal controls. Most of the patients were categorized as grade 2 (36%) and grade 3 (30%) of the K-L classification. Mean levels of MMP-3 and TIMP-1 were significantly elevated in both groups but they were not correlated with each other. MMP-3 continued to rise with increasing radiological grades until grade 4, where it fell unexpectedly. In conclusion, Phono-A and cartilage thickness measured by MSUS seem to support each other. They can be used as parameters for following up cartilage in OA of the knees. The first deals with the roughness of the cartilage surface and the second with its thickness, complementing each other. MMP-3 continues to rise in early and middle grades of OA, denoting cartilage destruction.
Literatur
1.
Zurück zum Zitat Blackburn WD, Chivers S, Bernreuter W. Cartilage imaging in osteoarthritis. Semin Arthritis Rheum. 1996;25:273–81.PubMedCrossRef Blackburn WD, Chivers S, Bernreuter W. Cartilage imaging in osteoarthritis. Semin Arthritis Rheum. 1996;25:273–81.PubMedCrossRef
2.
Zurück zum Zitat Heuter C. Grundriss der chirurgie. 3rd ed. Leipzig: FCW Vogel; 1882. Heuter C. Grundriss der chirurgie. 3rd ed. Leipzig: FCW Vogel; 1882.
3.
Zurück zum Zitat Bassiouni MH, El-Feki MB. Phonoarthrography of the knee in health and diseases. MSc thesis. Departmentof Rheumatology and Rehabilitation, Al-Azhar University; 1986. pp. 97–102. Bassiouni MH, El-Feki MB. Phonoarthrography of the knee in health and diseases. MSc thesis. Departmentof Rheumatology and Rehabilitation, Al-Azhar University; 1986. pp. 97–102.
4.
Zurück zum Zitat Bassiouni M, Bassiouni H, El-Feki M. Sensitivity versus specificity in phonoarthrography as an indicator for cartilage degeneration. Clin Rheumatol. 1995;14:135–42.PubMedCrossRef Bassiouni M, Bassiouni H, El-Feki M. Sensitivity versus specificity in phonoarthrography as an indicator for cartilage degeneration. Clin Rheumatol. 1995;14:135–42.PubMedCrossRef
5.
Zurück zum Zitat Naredo E, Cabero F, Palop MJ, Collado P, Cruz A, Crespo M. Ultrasonographic findings in knee osteoarthritis: a comparative study with clinical and radiographic assessment. Osteoarthritis Cartilage. 2005;13:568–74.PubMedCrossRef Naredo E, Cabero F, Palop MJ, Collado P, Cruz A, Crespo M. Ultrasonographic findings in knee osteoarthritis: a comparative study with clinical and radiographic assessment. Osteoarthritis Cartilage. 2005;13:568–74.PubMedCrossRef
6.
Zurück zum Zitat Naredo E, Acebes C, Möller I, Canillas F, de Agustín JJ, de Miguel E, et al. Ultrasound validity in the measurement of knee cartilage thickness. Ann Rheum Dis. 2009;68:1322–7.PubMedCrossRef Naredo E, Acebes C, Möller I, Canillas F, de Agustín JJ, de Miguel E, et al. Ultrasound validity in the measurement of knee cartilage thickness. Ann Rheum Dis. 2009;68:1322–7.PubMedCrossRef
7.
Zurück zum Zitat Mathiesen O, Konradsen L, Torp-Pedersen S, Jorgensen U. Ultrasonography and articular cartilage defects in the knee: an in vitro evaluation of the accuracy of cartilage thickness and defect size assessment. Knee Surg Sports Traumatol Arthrosc. 2004;12:440–3.PubMedCrossRef Mathiesen O, Konradsen L, Torp-Pedersen S, Jorgensen U. Ultrasonography and articular cartilage defects in the knee: an in vitro evaluation of the accuracy of cartilage thickness and defect size assessment. Knee Surg Sports Traumatol Arthrosc. 2004;12:440–3.PubMedCrossRef
8.
Zurück zum Zitat Wu J-J, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991;266:5625–8.PubMed Wu J-J, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991;266:5625–8.PubMed
9.
Zurück zum Zitat Okada Y, Konomi H, Yada T, Kimata K, Nagase H. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 1989;244:473–77. Okada Y, Konomi H, Yada T, Kimata K, Nagase H. Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 1989;244:473–77.
10.
Zurück zum Zitat Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678–85.PubMedCrossRef Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678–85.PubMedCrossRef
11.
Zurück zum Zitat Pelletier J-P, Mineau F, Faure MP, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990;33:1466–76.PubMedCrossRef Pelletier J-P, Mineau F, Faure MP, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990;33:1466–76.PubMedCrossRef
12.
Zurück zum Zitat Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier J-P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest. 1994;70:807–15.PubMed Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier J-P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest. 1994;70:807–15.PubMed
13.
Zurück zum Zitat Sellam J, Herrero-Beaumont G and Berenbaum F. Osteoarthritis: pathogenesis, clinical aspects and diagnosis. In: Bijlsma JWJ, editor. Eular compendium on rheumatic diseases. London: BMJ publishing Group; 2009. Sellam J, Herrero-Beaumont G and Berenbaum F. Osteoarthritis: pathogenesis, clinical aspects and diagnosis. In: Bijlsma JWJ, editor. Eular compendium on rheumatic diseases. London: BMJ publishing Group; 2009.
14.
Zurück zum Zitat Pratta MA, Tortorella MD, Arner EC. Age-related changes in aggrecan glycosylation affect cleavage by aggrecanase. J Biol Chem. 2000;275:39096–102.PubMedCrossRef Pratta MA, Tortorella MD, Arner EC. Age-related changes in aggrecan glycosylation affect cleavage by aggrecanase. J Biol Chem. 2000;275:39096–102.PubMedCrossRef
15.
Zurück zum Zitat Mercer E, Cawston TE, DeSilva M, Hazleman BL. Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J. 1985;231:505–10.PubMed Mercer E, Cawston TE, DeSilva M, Hazleman BL. Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J. 1985;231:505–10.PubMed
16.
Zurück zum Zitat Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M, Poole AR. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum. 1999;42(1):129–36.PubMedCrossRef Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M, Poole AR. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum. 1999;42(1):129–36.PubMedCrossRef
17.
Zurück zum Zitat Omura K, Takahashi M, Omura T. Changes in the concentration of plasma matrix metalloproteinases (MMP3 s) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol. 2002;21:488–92.PubMedCrossRef Omura K, Takahashi M, Omura T. Changes in the concentration of plasma matrix metalloproteinases (MMP3 s) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis. Clin Rheumatol. 2002;21:488–92.PubMedCrossRef
18.
Zurück zum Zitat Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 1994;37:1115–26.PubMedCrossRef Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum. 1994;37:1115–26.PubMedCrossRef
19.
Zurück zum Zitat Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today. 1998;4:130–7.PubMedCrossRef Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today. 1998;4:130–7.PubMedCrossRef
20.
Zurück zum Zitat Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 1993;36:181–9.PubMed Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 1993;36:181–9.PubMed
21.
Zurück zum Zitat Lohmander LS, Hoerrner LA, Dahlberg L, Roos H, Bjornsson S, Lark MW. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. J Rheumatol. 1993;20:1362–8.PubMed Lohmander LS, Hoerrner LA, Dahlberg L, Roos H, Bjornsson S, Lark MW. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. J Rheumatol. 1993;20:1362–8.PubMed
22.
Zurück zum Zitat Lohmander S, Brandt K, Mazzuka S, Katz B, Larsson S, Struglics A, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum. 2005;52:3160–7.PubMedCrossRef Lohmander S, Brandt K, Mazzuka S, Katz B, Larsson S, Struglics A, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum. 2005;52:3160–7.PubMedCrossRef
23.
Zurück zum Zitat Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039–49.PubMedCrossRef Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039–49.PubMedCrossRef
24.
Zurück zum Zitat Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rhem Dis. 1957;16:494–502.CrossRef Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rhem Dis. 1957;16:494–502.CrossRef
25.
Zurück zum Zitat Nagata Y. Joint sounds in gonarthrosis. J UOEH. 1988;10:47. Nagata Y. Joint sounds in gonarthrosis. J UOEH. 1988;10:47.
26.
Zurück zum Zitat Persin LS, Khvatova VA, Kopeĭkin VN, Kosenko SE, Kulikov NS. Phonoarthrographic method of diagnosing diseases of the temporomandibular joint and a device for its performance. Stomatologiia (Mosk). 1988;67(5):38–40. Persin LS, Khvatova VA, Kopeĭkin VN, Kosenko SE, Kulikov NS. Phonoarthrographic method of diagnosing diseases of the temporomandibular joint and a device for its performance. Stomatologiia (Mosk). 1988;67(5):38–40.
27.
Zurück zum Zitat Pozgan U, Caglic D, Rozman B, Nagase H, Turk V, Turk B, et al. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Biol Chem. 2010;391:571–9.PubMedCrossRef Pozgan U, Caglic D, Rozman B, Nagase H, Turk V, Turk B, et al. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Biol Chem. 2010;391:571–9.PubMedCrossRef
28.
Zurück zum Zitat Naito K, Takahashi M, Kushida K, Suzuki M, Ohishi T, Miura M, et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford). 1999;38:510–5.CrossRef Naito K, Takahashi M, Kushida K, Suzuki M, Ohishi T, Miura M, et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford). 1999;38:510–5.CrossRef
29.
Zurück zum Zitat Ribbens C, M Martin M, Porras Y, Franchimont N, Kaiser MJ, Jaspar JM, et al. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis . 2002;61:161–6.PubMedCrossRef Ribbens C, M Martin M, Porras Y, Franchimont N, Kaiser MJ, Jaspar JM, et al. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis . 2002;61:161–6.PubMedCrossRef
30.
Zurück zum Zitat Yung YO, Do JH, Kang HJ, Yoo SA, Yoon CH, Kim HA, et al. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients. Clin Exp Rheumatol. 2006;24:253–9. Yung YO, Do JH, Kang HJ, Yoo SA, Yoon CH, Kim HA, et al. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients. Clin Exp Rheumatol. 2006;24:253–9.
31.
Zurück zum Zitat Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U, et al. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol. 1998;110:416–21.PubMedCrossRef Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U, et al. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol. 1998;110:416–21.PubMedCrossRef
32.
Zurück zum Zitat Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678–85.PubMedCrossRef Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678–85.PubMedCrossRef
33.
Zurück zum Zitat Noyes FR, Mooar PA, Matthews DS, Butler DL. The symptomatic anterior cruciate-deficient knee. Part I: the long-term functional disability in athletically active individuals. J Bone Joint Surg Am. 1983;65:154–62.PubMed Noyes FR, Mooar PA, Matthews DS, Butler DL. The symptomatic anterior cruciate-deficient knee. Part I: the long-term functional disability in athletically active individuals. J Bone Joint Surg Am. 1983;65:154–62.PubMed
34.
Zurück zum Zitat Martino F, Ettorre GC, Patella V, Macarini L, Moretti B, Pesce V, et al. Articular cartilage echography as a criterion of the evolution of osteoarthritis of the knee. 14. Int J Clin Pharmacol Res. 1993;13:35–42.PubMed Martino F, Ettorre GC, Patella V, Macarini L, Moretti B, Pesce V, et al. Articular cartilage echography as a criterion of the evolution of osteoarthritis of the knee. 14. Int J Clin Pharmacol Res. 1993;13:35–42.PubMed
Metadaten
Titel
Phonoarthrography, musculoskeletal ultrasonography, and biochemical biomarkers for the evaluation of knee cartilage in osteoarthritis
verfasst von
Hassan M. Bassiouni
Mamoun El-Deeb
Nasser Kenawy
Ehab Abdul-Azim
Mamdouh Khairy
Publikationsdatum
01.10.2011
Verlag
Springer Japan
Erschienen in
Modern Rheumatology / Ausgabe 5/2011
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-011-0441-8

Weitere Artikel der Ausgabe 5/2011

Modern Rheumatology 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.